|
|
||||||||
From the Division of Neurology (Drs. Dinopoulos, Gilbert, Degrauw, and G. Chuck), Cincinnati Childrens Hospital Medical Center, Cincinnati, OH; Department of Medical Genetics (Drs. Kure, Sato, and Matsubara), Tohoku University School of Medicine, Japan.
Address correspondence and reprint requests to Dr. Argirios Dinopoulos, Cincinnati Childrens Hospital Medical Center, Division of Neurology, 3333 Burnet Avenue Cincinnati, OH 45229-3039; e-mail: argidino{at}yahoo.com
Three unrelated adult patients with mild hyperglycinemia, infantile hypotonia, mental retardation, behavioral hyperirritability, and aggressive outbursts were screened for glycine decarboxylase (GLDC) mutations; two novel missense mutations (A389V and R739H) were found. Both mutations had a 6 to 8% of normal GLDC activities when expressed in COS7 cells.
See Commentary, page 1105
Received October 20, 2004. Accepted in final form December 27, 2004.
Related Article
Neurology 2005 64: 1105.
This article has been cited by other articles:
![]() |
M. Oda, S. Kure, T. Sugawara, S. Yamaguchi, K. Kojima, T. Shinka, K. Sato, A. Narisawa, Y. Aoki, Y. Matsubara, et al. Direct Correlation Between Ischemic Injury and Extracellular Glycine Concentration in Mice With Genetically Altered Activities of the Glycine Cleavage Multienzyme System Stroke, July 1, 2007; 38(7): 2157 - 2164. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Pearl, J. L. Taylor, S. Trzcinski, and A. Sokohl The Pediatric Neurotransmitter Disorders J Child Neurol, May 1, 2007; 22(5): 606 - 616. [Abstract] [PDF] |
||||
![]() |
J. Kanno, T. Hutchin, F. Kamada, A. Narisawa, Y. Aoki, Y. Matsubara, and S. Kure Genomic deletion within GLDC is a major cause of non-ketotic hyperglycinaemia J. Med. Genet., March 1, 2007; 44(3): e69 - e69. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |